Keyphrases
P-glycoprotein (P-gp)
100%
Breast Cancer Resistance Protein
100%
Gefitinib
100%
ABCG2
100%
Active Efflux
100%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
100%
Mdr1a
33%
BCRP1
33%
Blood-brain Barrier
22%
Brain Tumor
22%
Brain Distribution
22%
Elacridar
22%
Clinical Trials
11%
Plasma Concentration
11%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
11%
Locally Advanced
11%
Glioma
11%
Central Nervous System
11%
In Vitro Study
11%
Oral Administration
11%
Epidermal Growth Factor Receptor
11%
Wild Mice
11%
Concentration Ratio
11%
High-grade Glioma
11%
Inulin
11%
Steady State
11%
Clinical Significance
11%
Madin-Darby Canine Kidney (MDCK) Cells
11%
Proteinase Inhibitor
11%
Brain-to-plasma Ratio
11%
Orally Active
11%
Tight Junction
11%
Intracellular Accumulation
11%
Dual Inhibitor
11%
Concurrent Administration
11%
Pharmacology, Toxicology and Pharmaceutical Science
P-Glycoprotein
100%
ABCG2
100%
Gefitinib
100%
Effusion
100%
Elacridar
22%
Intracranial Tumor
22%
Blood-Brain Barrier
22%
Clinical Trial
11%
Wild Type Mouse
11%
Non Small Cell Lung Cancer
11%
Protein Inhibitor
11%
Epidermal Growth Factor Receptor
11%
Inulin
11%